Immunogen reported $-22379000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
Amgen AMGN:US $ 3341M 185M
Astellas Pharma 4503:JP Y 8836M 84655M
AstraZeneca AZN:LN 4187M 687M
Bristol Myers Squibb BMY:US $ 5772M 404M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Emergent Biosolutions EBS:US $ 37.3M 311M
Exelixis EXEL:US $ 87.73M 30.84M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Immunogen IMGN:US $ -22.38M 11.71M
Intrexon XON:US $ -14.12M 3.05M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Macrogenics MGNX:US $ -63725000 8.44M
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Novartis NVS:US $ 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Seattle Genetics SGEN:US $ -115.96M 37.85M